We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVU
651
DELISTED
SUPERVALU Inc.
SVU
| $311K | 0.01% |
6,475
+771
| +14% | +$34.4K |
|
|
DWA
652
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $309K | 0.01% |
+11,613
| New | +$366K |
|
653
Manhattan Associates
MANH
$11.2B
| $308K | 0.01% |
+8,791
| New | +$306K |
|
654
Bath & Body Works
BBWI
$4.06B
| $307K | 0.01% |
+6,671
| New | +$301K |
|
655
MiMedx Group
MDXG
$602M
| $307K | 0.01% |
50,000
-150,000
| -75% | -$1.1M |
|
|
NSR
656
DELISTED
Neustar Inc
NSR
| $305K | ﹤0.01% |
9,377
+1,999
| +27% | +$77.2K |
|
|
FLG
657
Flagstar Bank National Association
FLG
$5.93B
| $304K | ﹤0.01% |
+6,298
| New | +$306K |
|
|
GAS
658
DELISTED
AGL Resources Inc
GAS
| $304K | ﹤0.01% |
6,196
-1,502
| -20% | -$70.8K |
|
659
AMC Global Media
AMCX
$492M
| $303K | ﹤0.01% |
+4,136
| New | +$289K |
|
660
AXIS Capital
AXS
$7.68B
| $301K | ﹤0.01% |
+6,550
| New | +$294K |
|
661
Incyte
INCY
$24.2B
| $300K | ﹤0.01% |
+5,595
| New | +$347K |
|
|
MON
662
DELISTED
Monsanto Co
MON
| $300K | ﹤0.01% |
+2,629
| New | +$293K |
|
663
Unum
UNM
$13.6B
| $299K | ﹤0.01% |
8,463
-3,896
| -32% | -$133K |
|
|
UFS
664
DELISTED
DOMTAR CORPORATION (New)
UFS
| $299K | ﹤0.01% |
5,328
-458
| -8% | -$23.6K |
|
|
CHK
665
DELISTED
Chesapeake Energy Corporation
CHK
| $295K | ﹤0.01% |
61
-9
| -13% | -$43.8K |
|
666
Aecom
ACM
$9.3B
| $294K | ﹤0.01% |
9,130
+56
| +0.6% | +$1.71K |
|
667
C.H. Robinson
CHRW
$17.4B
| $294K | ﹤0.01% |
+5,607
| New | +$305K |
|
668
MBIA
MBI
$261M
| $294K | ﹤0.01% |
21,006
+10,135
| +93% | +$129K |
|
669
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $293K | ﹤0.01% |
5,000
-5,000
| -50% | -$288K |
|
|
DST
670
DELISTED
DST Systems Inc.
DST
| $293K | ﹤0.01% |
6,164
-2,438
| -28% | -$114K |
|
671
ITT
ITT
$17.5B
| $292K | ﹤0.01% |
6,815
-69,550
| -91% | -$2.95M |
|
672
Northern Trust
NTRS
$33.3B
| $291K | ﹤0.01% |
+4,430
| New | +$275K |
|
673
Zillow
ZG
$7.94B
| $291K | ﹤0.01% |
9,876
-150,420
| -94% | -$4.29M |
|
674
Lowe's Companies
LOW
$117B
| $290K | ﹤0.01% |
5,923
-5,000
| -46% | -$241K |
|
675
F5
FFIV
$22.9B
| $288K | ﹤0.01% |
+2,694
| New | +$285K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.